Dispensary treatment in patients with malignant ovarian tumours
Published in the journal:
Prakt Gyn 2006; 10(4): 150-151
Summary
Dispensary treatment of patients with malignant ovarian tumours has to be provided by medical institutes which have provided the patient with complete treatment. Life long observation of the patients enables to evaluate the response to the treatment, to diagnose complication of the major treatment if any occur, to detect recurrence or persistance of the carcinoma, screening of other possible occurence of duplicate tumours, monitoring of patient’s psychological condition and collection of therapeutical data for oncology registers. Frequency of check-ups can be chosen individually; however, it is convenient to abide by general rules. It is indispensable for the examination to contain complete gynaecology check-up, basic laboratory tests, evaluation of the respective oncology markers and examination with screening methods according to the recommended algorithms.
Key words:
ovarian carcinoma – dispensary treatment
Zdroje
1. Výnos MZSV ČSR č. 3/1989, Věstník MZSV ČSR - Dispenzární péče o nemocné s přednádorovými stavy a novotvary a o povinném hlášení novotvarů.
2. Staging classifications and clinical practice guidelines of gynaecologic cancers by FIGO Committee on Gynaecologic Oncology and IGCS Guidelines Committee. 2nd ed. Ushers Print and Design 2003.
3. Freitag P. Onkogynekologie. Minimum pro praxi. Praha: Triton 2001: 106.
4. Onkologie. Doporučené postupy onkologické péče. 1. vyd. Praha: Galén 2000: 59.
5. Ozols RF. Update of the NCCN Ovarian Cancer Practice Guidelines. Oncology 1997; 11: 95-105.
6. Rob L, Svoboda B, Finek J et al. Guidelines gynekologických zhoubných nádorů (GZN) I. Standard – primární komplexní léčba ovariálních epiteliálních zhoubných nádorů. Ceska Gynekol 1999; 64(5): 331-337.
Štítky
Paediatric gynaecology Gynaecology and obstetrics Reproduction medicineČlánok vyšiel v časopise
Practical Gynecology
2006 Číslo 4
Najčítanejšie v tomto čísle
- Synechia vulvae infantum: risk factors for occurance and prevention
- Hormonal therapy and treatment of urine incontinence
- Foetus masculinus – indication for caesarean section in a pelvic presentation delivery
- Autoimmune thyroiditis in women of infertile couples